Mohr, Katharina http://orcid.org/0009-0000-5718-0549
Hobohm, Lukas http://orcid.org/0000-0002-4312-0366
Kaier, Klaus
Farmakis, Ioannis T. http://orcid.org/0000-0002-0586-6386
Valerio, Luca http://orcid.org/0000-0003-4466-0724
Barco, Stefano http://orcid.org/0000-0002-2618-347X
Abele, Christina
Münzel, Thomas http://orcid.org/0000-0001-5503-4150
Neusius, Thomas http://orcid.org/0000-0002-5097-9064
Konstantinides, Stavros http://orcid.org/0000-0001-6359-7279
Binder, Harald
Keller, Karsten http://orcid.org/0000-0002-0820-9584
Funding for this research was provided by:
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 11 January 2024
Accepted: 11 March 2024
First Online: 2 April 2024
Declarations
:
: KM reports no conflicts of interest. LH reports lecture/consultant fees from MSD and Janssen, outside the submitted work. K. Kaier, IF and LV report no conflict of interest. SB reports institutional research support by Bard, Boston Scientific, Medtronic, Bayer and Sanofi; and personal fee/honoraria from Boston Scientific, Penumbra and Viatris. CA, TM and TN report no conflict of interest; TM is principal investigator of the DZHK (German Center for Cardiovascular Research). SK reports lecture and advisory fees from Bayer AG, Boston Scientific, Daiichi-Sankyo, LumiraDx, MSD, Penumbra and Pfizer—Bristol-Myers Squibb; and research grants via his institution from Bayer AG, Boston Scientific, Daiichi-Sankyo, LumiraDx and Penumbra, all unrelated to the present work. HB and K. Keller report no conflict of interest.